Reaction
Cardiac Discomfort reporting signals
As of the last recalculation, Cardiac Discomfort appears in 1,988 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is TELMISARTAN (PRR 17.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Telmisartan | 29 | 17.2 | 17.3 |
| Esomeprazole Magnesium Capsule, Delayed Release | 19 | 13.8 | 13.8 |
| Esomeprazole Magnesium Delayed Release Capsules | 19 | 13.8 | 13.8 |
| Esomeprazole Magnesium Dihydrate | 19 | 13.8 | 13.8 |
| Linagliptin | 23 | 13.3 | 13.4 |
| Abaloparatide | 26 | 9.4 | 9.4 |
| Moxifloxacin Hydrochloride | 17 | 8.8 | 8.9 |
| Ticagrelor | 26 | 8.6 | 8.6 |
| Moxifloxacin | 11 | 8.2 | 8.2 |
| Epoprostenol | 10 | 8.0 | 8.0 |
| Selexipag | 18 | 7.4 | 7.4 |
| Pitavastatin Calcium | 7 | 7.2 | 7.2 |
| Sotalol Hydrochloride | 11 | 7.0 | 7.0 |
| Inclisiran | 5 | 6.5 | 6.5 |
| Riociguat | 19 | 6.2 | 6.2 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 6 | 6.0 | 6.0 |
| Macitentan | 38 | 5.8 | 5.8 |
| Treprostinil | 67 | 5.8 | 5.8 |
| Sildenafil Powder, | 19 | 5.6 | 5.6 |
| Agalsidase Beta | 4 | 4.5 | 4.5 |
| Vortioxetine | 7 | 4.3 | 4.3 |
| Sacubitril And Valsartan | 46 | 4.2 | 4.2 |
| Dronedarone | 4 | 4.1 | 4.1 |
| Ozanimod Hydrochloride | 3 | 3.8 | 3.8 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 6 | 3.8 | 3.8 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 3.7 | 3.7 |
| Selinexor | 3 | 3.6 | 3.6 |
| Tafamidis | 4 | 3.6 | 3.6 |
| Acalabrutinib | 4 | 3.5 | 3.5 |
| Ambrisentan | 39 | 3.3 | 3.3 |
| Suvorexant | 4 | 3.2 | 3.2 |
| Paliperidone Palmitate | 9 | 2.9 | 2.9 |
| Drospirenone And Ethinyl Estradiol | 12 | 2.9 | 2.9 |
| Ledipasvir And Sofosbuvir | 4 | 2.2 | 2.2 |